Beam Therapeutics logo

Senior Medical Science Liaison/Medical Science Liaison – Southwest Region

Beam Therapeutics
Remote friendly (Vega del Codorno, Castile-La Mancha, Spain)
United States
Medical Affairs

Role Summary

Senior Medical Science Liaison (MSL) for Beam Therapeutics’ Southwest Region. Owns a defined US territory with primary responsibility in sickle cell disease (SCD) and shared accountability across the Beam pipeline, including Alpha-1 antitrypsin deficiency (Alpha-1) and glycogen storage disease 1a (GSD). Architect territory strategy, onboard priority treatment centers, engage KOLs and healthcare professionals, generate actionable insights, and drive pre-commercial launch readiness in close collaboration with cross-functional partners.

Responsibilities

  • Develop and execute territory strategy: map treatment centers, referral networks, transplant/infusion sites, cell-collection capabilities, payers, and advocacy groups; prioritize accounts and set measurable objectives.
  • Support treatment center onboarding: coordinate scientific and operational readiness aligned with SOPs, compliance, and patient journey requirements; partner with internal teams for qualification and activation.
  • Build trusted relationships with KOLs and HCPs: deliver fair-balanced, evidence-based education on rare diseases, cell and gene therapy science, and Beam’s platform; foster advocacy and awareness.
  • Educate stakeholders on disease state, therapeutic landscape, and company platform to drive awareness and credibility in the rare disease and CGT space.
  • Generate high-quality insights from field interactions: synthesize trends and communicate actionable recommendations to Medical Affairs leadership and cross-functional partners.
  • Collaborate on pre-launch planning: align with Medical Strategy, Publications, Medical Information, Value & Evidence, and Medical Operations to ensure scientific messaging, data dissemination, and field tools are ready for first commercial launch.
  • Support clinical research activities: identify potential sites, assist with feasibility assessments, and promote best practices for enrollment and retention while maintaining medical/scientific independence.
  • Partner cross-functionally with Commercial, Market Access, and Clinical teams while preserving medical independence; coordinate account plans to ensure seamless patient access and avoid duplication.
  • Represent the company at congresses and external scientific meetings: plan and execute presence, engage in meaningful scientific exchanges, and follow up to strengthen visibility and credibility.
  • Provide education and resources to treatment centers on operational readiness for advanced therapies, including apheresis and cell-handling processes.
  • Serve as a trusted resource for compliance and ethical standards: ensure all interactions and materials meet company policies, regulatory requirements, and industry codes.
  • Maintain operational excellence: document activities and insights in CRM, monitor KPIs, and continuously improve processes, content, and tools.
  • Prepare and deliver training for internal teams and external stakeholders on rare disease management and CGT fundamentals to support launch readiness.
  • Act as a scientific ambassador for the company: articulate the value of the platform and pipeline to diverse audiences including clinicians, researchers, and advocacy groups.
  • Monitor evolving evidence and competitive landscape in rare disease and CGT; share updates internally to inform strategy and decision-making.

Qualifications

  • Advanced scientific degree (PharmD, PhD, MD, or equivalent).
  • ~10+ years industry experience in Medical Affairs with significant Field Medical tenure.
  • Rare disease expertise required; hematology strongly preferred with emphasis on SCD.
  • Small biotech experience preferred; demonstrated impact in resource-constrained settings.
  • Launch experience (pre‑approval to post‑launch), ideally in CGT or complex specialty (buy‑and‑bill) environments.
  • Proven territory management and account planning capability across complex ecosystems (academic centers, community networks, payers, advocacy).
  • Independent, proactive operator with strong ownership;
  • Cross‑functional collaboration with Clinical, Regulatory, Commercial, Medical Operations, and Publications while maintaining medical/scientific integrity.
  • Outstanding communication skills; ability to translate complex science into clear, credible narratives.
  • Analytical strength for insight collection, synthesis, and actionable recommendations.
  • Travel up to ~60% across assigned territory.